Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion devicemaker Hospira, and says the deal will close in early September. The FTC has ordered Pfizer to sell four drugs in order to preserve competition.
The federal government says healthcare facilities should stop using Hospira's Symbiq medication infusion pump because of its vulnerability to hacking.
The Food and Drug Administration is reporting shortages of pre-filled syringes of epinephrine, which are most commonly used to treat individuals who are in cardiac arrest.
Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer, Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their...
Federal regulators have approved the first biosimilar drug to be sold in the U.S., a move that could lower treatment costs as biosimilars compete with what historically had been more expensive medications.
Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the patents protecting the company's top-selling antibiotic just hours after that deal was announced Monday.
Drugmaker Hospira said Wednesday that it received a warning letter from the Food and Drug Administration regarding poor manufacturing quality at one of its facilities in Australia.
Healthcare supply, analytics and consulting company Premier agreed Tuesday to acquire TheraDoc, a clinical surveillance software company, for $117 million, augmenting Premier's already sizable footprint in the clinical-safety solutions market.
Pharmaceutical and medical-device maker Hospira saw its earnings soar in the second quarter of 2014, thanks mostly to large sales of drugs that have been in short supply.
The American Hospital Association is pushing the Food and Drug Administration to be more aggressive in getting manufacturers of saline and other IV fluids to increase production to alleviate shortages.
A worsening shortage of IV saline solution, one of the most common products used in hospitals, is causing concern among healthcare providers having trouble locating saline products during this increasingly severe flu season.
ActiveCare, which provides remote health monitoring for diabetes and chronic disease management, has named Jonathan Olson its chief technology officer.